ID   SETD4_HUMAN             Reviewed;         440 AA.
AC   Q9NVD3; B4DT14; D3DSG2; D3DSG4; Q8NE19; Q9BU46;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-JUN-2023, entry version 173.
DE   RecName: Full=SET domain-containing protein 4 {ECO:0000305};
DE            EC=2.1.1.- {ECO:0000269|PubMed:31308046};
DE            EC=2.1.1.364 {ECO:0000250|UniProtKB:P58467};
GN   Name=SETD4 {ECO:0000303|PubMed:24738023, ECO:0000312|HGNC:HGNC:1258};
GN   Synonyms=C21orf18 {ECO:0000312|HGNC:HGNC:1258}, C21orf27
GN   {ECO:0000312|HGNC:HGNC:1258};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=11707072; DOI=10.1006/geno.2001.6640;
RA   Reymond A., Friedli M., Neergaard Henrichsen C., Chapot F., Deutsch S.,
RA   Ucla C., Rossier C., Lyle R., Guipponi M., Antonarakis S.E.;
RT   "From PREDs and open reading frames to cDNA isolation: revisiting the human
RT   chromosome 21 transcription map.";
RL   Genomics 78:46-54(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A; 3 AND 4).
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=24738023;
RA   Faria J.A., Correa N.C., de Andrade C., de Angelis Campos A.C.,
RA   Dos Santos Samuel de Almeida R., Rodrigues T.S., de Goes A.M., Gomes D.A.,
RA   Silva F.P.;
RT   "SET domain-containing protein 4 (SETD4) is a newly identified Cytosolic
RT   and nuclear lysine methyltransferase involved in breast cancer cell
RT   proliferation.";
RL   J. Cancer Sci. Ther. 5:58-65(2013).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF GLY-61 AND ASP-233.
RX   PubMed=31308046; DOI=10.1158/0008-5472.can-19-1084;
RA   Ye S., Ding Y.F., Jia W.H., Liu X.L., Feng J.Y., Zhu Q., Cai S.L.,
RA   Yang Y.S., Lu Q.Y., Huang X.T., Yang J.S., Jia S.N., Ding G.P., Wang Y.H.,
RA   Zhou J.J., Chen Y.D., Yang W.J.;
RT   "SET domain-containing protein 4 epigenetically controls breast cancer stem
RT   cell quiescence.";
RL   Cancer Res. 79:4729-4743(2019).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] GLY-420.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Histone-lysine N-methyltransferase that acts as a regulator
CC       of cell proliferation, cell differentiation and inflammatory response
CC       (PubMed:31308046). Regulates the inflammatory response by mediating
CC       mono- and dimethylation of 'Lys-4' of histone H3 (H3K4me1 and H3K4me2,
CC       respectively), leading to activate the transcription of pro-
CC       inflammatory cytokines IL6 and TNF-alpha (By similarity). Also involved
CC       in the regulation of stem cell quiescence by catalyzing the
CC       trimethylation of 'Lys-20' of histone H4 (H4K20me3), thereby promoting
CC       heterochromatin formation (PubMed:31308046). Involved in proliferation,
CC       migration, paracrine and myogenic differentiation of bone marrow
CC       mesenchymal stem cells (BMSCs) (By similarity).
CC       {ECO:0000250|UniProtKB:P58467, ECO:0000269|PubMed:31308046}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(4)-[histone H3] + S-adenosyl-L-methionine = H(+) +
CC         N(6)-methyl-L-lysyl(4)-[histone H3] + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:60264, Rhea:RHEA-COMP:15543, Rhea:RHEA-COMP:15547,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929; EC=2.1.1.364;
CC         Evidence={ECO:0000250|UniProtKB:P58467};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-methyl-L-lysyl(4)-[histone H3] + S-adenosyl-L-methionine
CC         = H(+) + N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:60268, Rhea:RHEA-COMP:15540, Rhea:RHEA-
CC         COMP:15543, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC         ChEBI:CHEBI:61929, ChEBI:CHEBI:61976;
CC         Evidence={ECO:0000250|UniProtKB:P58467};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(20)-[histone H4] + S-adenosyl-L-methionine = H(+) +
CC         N(6)-methyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:60344, Rhea:RHEA-COMP:15554, Rhea:RHEA-COMP:15555,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929;
CC         Evidence={ECO:0000269|PubMed:31308046};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-methyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-methionine
CC         = H(+) + N(6),N(6)-dimethyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:60348, Rhea:RHEA-COMP:15555, Rhea:RHEA-
CC         COMP:15556, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC         ChEBI:CHEBI:61929, ChEBI:CHEBI:61976;
CC         Evidence={ECO:0000269|PubMed:31308046};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6),N(6)-dimethyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-
CC         methionine = H(+) + N(6),N(6),N(6)-trimethyl-L-lysyl(20)-[histone H4]
CC         + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:61992, Rhea:RHEA-
CC         COMP:15556, Rhea:RHEA-COMP:15998, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961,
CC         ChEBI:CHEBI:61976; Evidence={ECO:0000269|PubMed:31308046};
CC   -!- INTERACTION:
CC       Q9NVD3-4; Q9H5X1: CIAO2A; NbExp=3; IntAct=EBI-23709068, EBI-752069;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:24738023}.
CC       Nucleus {ECO:0000269|PubMed:24738023}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A;
CC         IsoId=Q9NVD3-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9NVD3-2; Sequence=VSP_004146;
CC       Name=3;
CC         IsoId=Q9NVD3-3; Sequence=VSP_026578;
CC       Name=4;
CC         IsoId=Q9NVD3-4; Sequence=VSP_054087, VSP_054088;
CC   -!- MISCELLANEOUS: [Isoform B]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. SETD4 family. {ECO:0000255|PROSITE-ProRule:PRU00190,
CC       ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF391112; AAL34503.1; -; mRNA.
DR   EMBL; AK001660; BAA91819.1; -; mRNA.
DR   EMBL; AK300009; BAG61826.1; -; mRNA.
DR   EMBL; AP000688; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09757.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09758.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09759.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09760.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09762.1; -; Genomic_DNA.
DR   EMBL; BC002898; AAH02898.1; -; mRNA.
DR   EMBL; BC036556; AAH36556.1; -; mRNA.
DR   CCDS; CCDS13640.1; -. [Q9NVD3-1]
DR   CCDS; CCDS42923.1; -. [Q9NVD3-4]
DR   CCDS; CCDS74792.1; -. [Q9NVD3-3]
DR   RefSeq; NP_001007260.1; NM_001007259.2. [Q9NVD3-4]
DR   RefSeq; NP_001007262.1; NM_001007261.2.
DR   RefSeq; NP_001273681.1; NM_001286752.1. [Q9NVD3-3]
DR   RefSeq; NP_059134.1; NM_017438.4. [Q9NVD3-1]
DR   RefSeq; XP_011527938.1; XM_011529636.1. [Q9NVD3-1]
DR   RefSeq; XP_011527939.1; XM_011529637.1. [Q9NVD3-1]
DR   RefSeq; XP_011527940.1; XM_011529638.2. [Q9NVD3-1]
DR   RefSeq; XP_011527941.1; XM_011529639.1. [Q9NVD3-1]
DR   RefSeq; XP_011527942.1; XM_011529640.2. [Q9NVD3-1]
DR   RefSeq; XP_011527944.1; XM_011529642.1.
DR   RefSeq; XP_011527945.1; XM_011529643.1. [Q9NVD3-3]
DR   RefSeq; XP_011527946.1; XM_011529644.1. [Q9NVD3-3]
DR   RefSeq; XP_016883892.1; XM_017028403.1.
DR   RefSeq; XP_016883893.1; XM_017028404.1.
DR   RefSeq; XP_016883894.1; XM_017028405.1. [Q9NVD3-4]
DR   AlphaFoldDB; Q9NVD3; -.
DR   SMR; Q9NVD3; -.
DR   BioGRID; 119892; 21.
DR   IntAct; Q9NVD3; 16.
DR   MINT; Q9NVD3; -.
DR   STRING; 9606.ENSP00000382163; -.
DR   iPTMnet; Q9NVD3; -.
DR   PhosphoSitePlus; Q9NVD3; -.
DR   BioMuta; SETD4; -.
DR   DMDM; 12229715; -.
DR   MassIVE; Q9NVD3; -.
DR   PaxDb; Q9NVD3; -.
DR   PeptideAtlas; Q9NVD3; -.
DR   ProteomicsDB; 82779; -. [Q9NVD3-1]
DR   ProteomicsDB; 82781; -. [Q9NVD3-3]
DR   Antibodypedia; 8172; 140 antibodies from 21 providers.
DR   DNASU; 54093; -.
DR   Ensembl; ENST00000332131.9; ENSP00000329189.4; ENSG00000185917.14. [Q9NVD3-1]
DR   Ensembl; ENST00000399207.5; ENSP00000382158.1; ENSG00000185917.14. [Q9NVD3-4]
DR   Ensembl; ENST00000399208.6; ENSP00000382159.2; ENSG00000185917.14. [Q9NVD3-4]
DR   Ensembl; ENST00000399212.5; ENSP00000382161.1; ENSG00000185917.14. [Q9NVD3-3]
DR   Ensembl; ENST00000399215.5; ENSP00000382163.1; ENSG00000185917.14. [Q9NVD3-1]
DR   GeneID; 54093; -.
DR   KEGG; hsa:54093; -.
DR   MANE-Select; ENST00000332131.9; ENSP00000329189.4; NM_017438.5; NP_059134.1.
DR   UCSC; uc002yuw.3; human. [Q9NVD3-1]
DR   AGR; HGNC:1258; -.
DR   CTD; 54093; -.
DR   DisGeNET; 54093; -.
DR   GeneCards; SETD4; -.
DR   HGNC; HGNC:1258; SETD4.
DR   HPA; ENSG00000185917; Low tissue specificity.
DR   neXtProt; NX_Q9NVD3; -.
DR   OpenTargets; ENSG00000185917; -.
DR   PharmGKB; PA25814; -.
DR   VEuPathDB; HostDB:ENSG00000185917; -.
DR   eggNOG; KOG1337; Eukaryota.
DR   GeneTree; ENSGT00940000153577; -.
DR   HOGENOM; CLU_029120_3_0_1; -.
DR   InParanoid; Q9NVD3; -.
DR   OMA; NTRSFYW; -.
DR   OrthoDB; 11215at2759; -.
DR   PhylomeDB; Q9NVD3; -.
DR   TreeFam; TF106421; -.
DR   PathwayCommons; Q9NVD3; -.
DR   SignaLink; Q9NVD3; -.
DR   BioGRID-ORCS; 54093; 15 hits in 1167 CRISPR screens.
DR   ChiTaRS; SETD4; human.
DR   GenomeRNAi; 54093; -.
DR   Pharos; Q9NVD3; Tbio.
DR   PRO; PR:Q9NVD3; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; Q9NVD3; protein.
DR   Bgee; ENSG00000185917; Expressed in oocyte and 163 other tissues.
DR   ExpressionAtlas; Q9NVD3; baseline and differential.
DR   Genevisible; Q9NVD3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046975; F:histone H3K36 methyltransferase activity; IBA:GO_Central.
DR   GO; GO:0042800; F:histone H3K4 methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0140945; F:histone H3K4 monomethyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042799; F:histone H4K20 methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140944; F:histone H4K20 monomethyltransferase activity; IEA:RHEA.
DR   GO; GO:0140941; F:histone H4K20me methyltransferase activity; IEA:RHEA.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0018027; P:peptidyl-lysine dimethylation; IBA:GO_Central.
DR   GO; GO:0018026; P:peptidyl-lysine monomethylation; IBA:GO_Central.
DR   GO; GO:0018023; P:peptidyl-lysine trimethylation; IBA:GO_Central.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0071863; P:regulation of cell proliferation in bone marrow; ISS:UniProtKB.
DR   CDD; cd19177; SET_SETD4; 1.
DR   Gene3D; 3.90.1420.10; Rubisco LSMT, substrate-binding domain; 1.
DR   Gene3D; 3.90.1410.10; set domain protein methyltransferase, domain 1; 1.
DR   InterPro; IPR015353; Rubisco_LSMT_subst-bd.
DR   InterPro; IPR036464; Rubisco_LSMT_subst-bd_sf.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR046341; SET_dom_sf.
DR   InterPro; IPR016852; SET_MeTrfase.
DR   InterPro; IPR044429; SETD4_SET.
DR   PANTHER; PTHR13271:SF151; SET DOMAIN-CONTAINING PROTEIN 4; 1.
DR   PANTHER; PTHR13271; UNCHARACTERIZED PUTATIVE METHYLTRANSFERASE; 1.
DR   Pfam; PF09273; Rubis-subs-bind; 1.
DR   Pfam; PF00856; SET; 1.
DR   PIRSF; PIRSF027158; Lys_MTase_YDR198C_prd; 1.
DR   SUPFAM; SSF82199; SET domain; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Inflammatory response; Methyltransferase;
KW   Nucleus; Reference proteome; S-adenosyl-L-methionine; Transferase.
FT   CHAIN           1..440
FT                   /note="SET domain-containing protein 4"
FT                   /id="PRO_0000079509"
FT   DOMAIN          48..273
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         272
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   VAR_SEQ         1..25
FT                   /note="MQKGKGRTSRIRRRKLCGSSESRGV -> M (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_026578"
FT   VAR_SEQ         70..440
FT                   /note="EGQMIISLPESCLLTTDTVIRSYLGAYITKWKPPPSPLLALCTFLVSEKHAG
FT                   HRSLWKPYLEILPKAYTCPVCLEPEVVNLLPKSLKAKAEEQRAHVQEFFASSRDFFSSL
FT                   QPLFAEAVDSIFSYSALLWAWCTVNTRAVYLRPRQRECLSAEPDTCALAPYLDLLNHSP
FT                   HVQVKAAFNEETHSYEIRTTSRWRKHEEVFICYGPHDNQRLFLEYGFVSVHNPHACVYV
FT                   SREILVKYLPSTDKQMDKKISILKDHGYIENLTFGWDGPSWRLLTALKLLCLEAEKFTC
FT                   WKKVLLGEVISDTNEKTSLDIAQKICYYFIEETNAVLQKVSHMKDEKEALINQLTLVES
FT                   LWTEELKILRASAETLHSLQTAFT -> VEASSISSAGAVHLFSFRKACWAPISLEALP
FT                   GDFTQGVYLPCLFGAGSGEPSSQIFKSKG (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:11707072,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_004146"
FT   VAR_SEQ         301..307
FT                   /note="EILVKYL -> GWNQLCS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054087"
FT   VAR_SEQ         308..440
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054088"
FT   VARIANT         387
FT                   /note="I -> V (in dbSNP:rs2835239)"
FT                   /id="VAR_021948"
FT   VARIANT         420
FT                   /note="E -> G (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035988"
FT   MUTAGEN         61
FT                   /note="G->V: Abolished histone-lysine N-methyltransferase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:31308046"
FT   MUTAGEN         233
FT                   /note="D->A: Abolished histone-lysine N-methyltransferase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:31308046"
FT   CONFLICT        301..440
FT                   /note="EILVKYLPSTDKQMDKKISILKDHGYIENLTFGWDGPSWRLLTALKLLCLEA
FT                   EKFTCWKKVLLGEVISDTNEKTSLDIAQKICYYFIEETNAVLQKVSHMKDEKEALINQL
FT                   TLVESLWTEELKILRASAETLHSLQTAFT -> GWNQLCS (in Ref. 5;
FT                   AAH02898)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   440 AA;  50416 MW;  9EBCAA05397BE287 CRC64;
     MQKGKGRTSR IRRRKLCGSS ESRGVNESHK SEFIELRKWL KARKFQDSNL APACFPGTGR
     GLMSQTSLQE GQMIISLPES CLLTTDTVIR SYLGAYITKW KPPPSPLLAL CTFLVSEKHA
     GHRSLWKPYL EILPKAYTCP VCLEPEVVNL LPKSLKAKAE EQRAHVQEFF ASSRDFFSSL
     QPLFAEAVDS IFSYSALLWA WCTVNTRAVY LRPRQRECLS AEPDTCALAP YLDLLNHSPH
     VQVKAAFNEE THSYEIRTTS RWRKHEEVFI CYGPHDNQRL FLEYGFVSVH NPHACVYVSR
     EILVKYLPST DKQMDKKISI LKDHGYIENL TFGWDGPSWR LLTALKLLCL EAEKFTCWKK
     VLLGEVISDT NEKTSLDIAQ KICYYFIEET NAVLQKVSHM KDEKEALINQ LTLVESLWTE
     ELKILRASAE TLHSLQTAFT
//
